|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fu J, Li Y, Li Z and Li N: Clinical
utility of decarboxylation prothrombin combined with α-fetoprotein
for diagnosing primary hepatocellular carcinoma. Biosci Rep.
38:BSR201800442018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dhir M, Melin AA, Douaiher J, Lin C, Zhen
WK, Hussain SM, Geschwind JF, Doyle MB, Abou-Alfa GK and Are C: A
Review and update of treatment options and controversies in the
management of hepatocellular carcinoma. Ann Surg. 263:1112–1125.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weber A, Pennise CR, Babcock GG and Fowler
VM: Tropomodulin caps the pointed ends of actin filaments. J Cell
Biol. 127:1627–1635. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Narita A, Oda T and Maéda Y: Structural
basis for the slow dynamics of the actin filament pointed end. EMBO
J. 30:1230–1237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fischer RS and Fowler VM: Tropomodulins:
Life at the slow end. Trends Cell Biol. 13:593–601. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weber KL, Fischer RS and Fowler VM: Tmod3
regulates polarized epithelial cell morphology. J Cell Sci.
120:3625–3632. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim CY, Bi X, Wu D, Kim JB, Gunning PW,
Hong W and Han W: Tropomodulin3 is a novel Akt2 effector regulating
insulin-stimulated GLUT4 exocytosis through cortical actin
remodeling. Nat Commun. 6:59512015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamashiro S, Gokhin DS, Kimura S, Nowak RB
and Fowler VM: Tropomodulins: Pointed-end capping proteins that
regulate actin filament architecture in diverse cell types.
Cytoskeleton. 69:337–370. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cox-Paulson EA, Walck-Shannon E, Lynch AM,
Yamashiro S, Zaidel-Bar R, Eno CC, Ono S and Hardin J: Tropomodulin
protects α-catenin-dependent junctional-actin networks under stress
during epithelial morphogenesis. Curr Biol. 22:1500–1505. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moyer JD, Nowak RB, Kim NE, Larkin SK,
Peters LL, Hartwig J, Kuypers FA and Fowler VM: Tropomodulin 1-null
mice have a mild spherocytic elliptocytosis with appearance of
tropomodulin 3 in red blood cells and disruption of the membrane
skeleton. Blood. 116:2590–2599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sui Z, Nowak RB, Sanada C, Halene S,
Krause DS and Fowler VM: Regulation of actin polymerization by
tropomodulin-3 controls megakaryocyte actin organization and
platelet biogenesis. Blood. 126:520–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sui Z, Nowak RB, Bacconi A, Kim NE, Liu H,
Li J, Wickrema A, An XL and Fowler VM: Tropomodulin3-null
mice are embryonic lethal with anemia due to impaired erythroid
terminal differentiation in the fetal liver. Blood. 123:758–767.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cox PR and Zoghbi HY: Sequencing,
expression analysis, and mapping of three unique human tropomodulin
genes and their mouse orthologs. Genomics. 63:97–107. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fischer RS, Yarmola EG, Weber KL, Speicher
KD, Speicher DW, Bubb MR and Fowler VM: Tropomodulin 3 binds to
actin monomers. J Biol Chem. 281:36454–36465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pollard TD and Cooper JA: Actin, a central
player in cell shape and movement. Science. 326:1208–1212. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Diz-Muñoz A, Fletcher DA and Weiner OD:
Use the force: Membrane tension as an organizer of cell shape and
motility. Trends Cell Biol. 23:47–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jo YJ, Jang WI, Kim NH and Namgoong S:
Tropomodulin-3 is essential in asymmetric division during mouse
oocyte maturation. Sci Rep. 6:292042016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chaigne A, Campillo C, Voituriez R, Gov
NS, Sykes C, Verlhac MH and Terret ME: F-actin mechanics control
spindle centring in the mouse zygote. Nat Commun. 7:102532016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paez AV, Pallavicini C, Schuster F,
Valacco MP, Giudice J, Ortiz EG, Anselmino N, Labanca E, Binaghi M,
Salierno M, et al: Heme oxygenase-1 in the forefront of a
multi-molecular network that governs cell-cell contacts and
filopodia-induced zippering in prostate cancer. Cell Death Dis.
7:e25702016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pawlak G, McGarvey TW, Nguyen TB,
Tomaszewski JE, Puthiyaveettil R, Malkowicz SB and Helfman DM:
Alterations in tropomyosin isoform expression in human transitional
cell carcinoma of the urinary bladder. Int J Cancer. 110:368–373.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction pathways activated by stress and inflammation:
A 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Luca A, Maiello MR, D'Alessio A,
Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT
signalling pathways: Role in cancer pathogenesis and implications
for therapeutic approaches. Expert Opin Ther Targets. 16 (Suppl
2):S17–S27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao YJ, Fang CC, Yen CH, Hsu SM, Wang CK,
Huang SF, Liang YC, Lin YY, Chu YT and Arthur Chen YM: Niemann-Pick
type C2 protein regulates liver cancer progression via modulating
ERK1/2 pathway: Clinicopathological correlations and therapeutical
implications. Int J Cancer. 137:1341–1351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chung W, Kim M, de la Monte S, Longato L,
Carlson R, Slagle BL, Dong X and Wands JR: Activation of signal
transduction pathways during hepatic oncogenesis. Cancer Lett.
370:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang Y, Liu G, Xie C, Qian K, Lei X, Liu
Q, Liu G, Cao Z, Fu J, Du H, et al: Pharmacological inhibition of
TRPV4 channel suppresses malignant biological behavior of
hepatocellular carcinoma via modulation of ERK signaling pathway.
Biomed Pharmacother. 101:910–919. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tashiro E, Tsuchiya A and Imoto M:
Functions of cyclin D1 as an oncogene and regulation of cyclin D1
expression. Cancer Sci. 98:629–635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng L, Wang X, Liao W, Liu J, Liao Y and
He Q: BAF53a is a potential prognostic biomarker and promotes
invasion and epithelial-mesenchymal transition of glioma cells.
Oncol Rep. 38:3327–3334. 2017.PubMed/NCBI
|
|
35
|
Chen JH, Zhou LY, Xu S, Zheng YL, Wan YF
and Hu CP: Overexpression of lncRNA HOXA11-AS promotes cell
epithelial-mesenchymal transition by repressing miR-200b in
non-small cell lung cancer. Cancer Cell Int. 17:642017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma J, Zeng S, Zhang Y, Deng G, Qu Y, Guo
C, Yin L, Han Y, Cai C, Li Y, et al: BMP4 promotes oxaliplatin
resistance by an induction of epithelial-mesenchymal transition via
MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Lett.
411:117–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
